Company Filing History:
Years Active: 2010
Title: Masaharu Nakayama: Innovator in Thrombin Receptor Antagonism
Introduction
Masaharu Nakayama is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of thrombin receptor antagonists. His innovative work has the potential to impact the treatment of various pathological conditions.
Latest Patents
Masaharu Nakayama holds a patent for a triazole derivative and its use as a thrombin receptor antagonist. This invention relates to a compound that exhibits antagonistic action on the thrombin receptor, specifically PAR-1. The patent outlines a compound represented by a specific formula, which includes various substituents that enhance its therapeutic efficacy. The thrombin receptor antagonist developed by Nakayama is useful for the prophylaxis or treatment of conditions mediated by PAR-1.
Career Highlights
Nakayama is associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work at Takeda has allowed him to focus on innovative drug development, contributing to advancements in medical science. His expertise in pharmacology and medicinal chemistry has been instrumental in his research endeavors.
Collaborations
Throughout his career, Masaharu Nakayama has collaborated with notable colleagues, including Keiji Kubo and Mamoru Tobisu. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.
Conclusion
Masaharu Nakayama's contributions to the field of thrombin receptor antagonism exemplify the impact of innovative research in pharmaceuticals. His patent and work at Takeda Pharmaceutical Company Limited highlight his role as a key inventor in advancing medical treatments.